Quality Control Associate

Job Description

Req #: 1902662
Location: Munich, Bavaria, Germany
Job Category: Quality
Work Location: Grillparzerstrasse 10-18 81675
Organization: Quality Control
Employee Status: Full-time
Job Type: Regular

Juno Therapeutics is a clinical-stage company developing novel cellular immunotherapies based on two distinct and complementary platforms – Chimeric Antigen Receptors (CARs) and T Cell Receptors (TCRs) technologies. Our goal is to revolutionize medicine by re-engaging the body’s immune system to treat cancer.

• Perform routine QC testing on raw materials, IPC samples, Product and stability samples according to established SOPs and standards
• Assessment of analytical results and GMP state of the art documentation
• Analytical test method development, supporting test method transfers, method qualification/validation
• Perform equipment qualification, reagent preparation, issuance of laboratory documents and other tasks necessary to perform testing in the laboratory
• Write test methods, equipment SOPs and other relevant QC documents
• Perform lab investigations according to established standards

Job Description:

• Experience with test methods such as HPLC, UV absorption, SDS-PAGE and other techniques used in protein analytical testing. Knowledge in flow cytometry/FACS testing would be beneficial.
• Good written and spoken knowledge in English
• Experience in different PC based software evaluation
• Experience with Microsoft Office
• Ability to work in a fast developing environment, according to set priorities and timelines

Basic Qualifications:

• Laboratory Technician degree (CTA, BTA etc.) with relevant experience in quality control Additional GMP experience is highly appreciated but not mandatory

About Us
COMMITTED TO IMPROVING THE LIVES OF PATIENTS WORLDWIDE
At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our vision as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.
"At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients."
There are more than 300 clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocytic leukemia (CLL), non-Hodgkin’s lymphoma (NHL), triple-negative breast cancer and pancreatic cancer. As committed as we are to clinical accomplishment, we are equally committed to patient support, which is a guiding principle at Celgene. We believe all who can benefit from our discoveries should have the opportunity to do so. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies.